2-amino-9-[4-(4-methoxy-phenoxy) - piperid in -1-yl] -4-phenyl-indeno [1,2-d] pyrimidin -5 -one and its use as a highly selective adenosine A2A receptor antagonist

Details for Australian Patent Application No. 2010313574 (hide)

Owner Janssen Pharmaceutica NV

Inventors Jackson, Paul F.; Powell, Mark; Shook, Brian Christopher; Wang, Aihua

Agent Shelston IP

Pub. Number AU-A-2010313574

PCT Pub. Number WO2011/053507

Priority 61/255,925 29.10.09 US

Filing date 21 October 2010

Wipo publication date 5 May 2011

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

Event Publications

17 May 2012 PCT application entered the National Phase

  PCT publication WO2011/053507 Priority application(s): WO2011/053507

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010313575-Alkyl substituted arylindenopyrimidines and their use as highly selective Adenosine A2a receptor antagonists

2010313571-Solid pharmaceutical compositions containing an integrase inhibitor